This article presents the average 12-month stock price targets for the 5 largest Canadian cannabis licensed producers (LPs) - along with their percentage changes from today's price - according to the Wall Street analysts that cover these companies. In addition, the article provides the analyst consensus buy, hold and sell recommendations to help you with your investment decisions.

The above information is provided below in descending order of the expected percentage changes from today's stock price, as follows:

1. OrganiGram (OGI)
   • average price target is $1.37, a +86.14% increase from the March 6th price of $0.74
   • the highest analyst price target is $1.60, the lowest forecast is $1.10
   • consensus rating of Strong Buy is based on 3 buy ratings, 1 hold ratings and 0 sell ratings of 4 Wall Street analysts offering 12 month price targets for Organigram in the last 3 months
   • Source
2. Aurora (ACB)
   • average price target is $1.07, a +30.15% change from the March 6th price of $0.82
   • the highest analyst price target is $1.29, the lowest forecast is $0.88
   • consensus rating of Hold is based on 0 buy rating, 4 hold ratings and 0 sell ratings of 4 Wall Street analysts offering 12 month price targets for Aurora in the last 3 months
   • Source
3. Tilray (TLRY)
   • average price target is $3.38, a +25.65% change from the March 6th price of $2.69
   • the highest analyst price target is $5.00, the lowest forecast is $2.80
   • consensus rating of Hold is based on 1 buy rating, 5 hold ratings and 0 sell ratings of 6 Wall Street analysts offering 12 month price targets for Tilray in the last 3 months
   • Source
4. Cronos (CRON)
   • average price target is $2.58, a +28.04% increase from the March 6th price of $2.02
   • the highest analyst price target is $3.12, the lowest forecast is $2.10
   • consensus rating of Hold is based on 2 buy ratings, 1 hold ratings and 1 sell ratings of 4 Wall Street analysts offering 12 month price targets for Cronos in the last 3 months
   • Source
5. Canopy Growth (CGC)
   • average price target is $2.15, a -3.59% decrease from the March 6th price of $2.23
   • the highest analyst price target is $3.20, the lowest forecast is $1.29
   • consensus rating of Moderate Sell is based on 0 buy ratings, 3 hold ratings and 4 sell ratings of 7 Wall Street analysts offering 12 month price targets for Canopy in the last 3 months
   • Source

The average analyst price target for the above LPs is +22.4% from today's price with 1 Strong Buy recommendation, 3 Holds and 1 Moderate Sell. That being said, the above 5 stocks currently are -5.6% YTD and showing month-over-month weakness which begs the question: "What do they know that we don't?"

More By This Author:

Compass Pathways - Entering A Brave New World
GH Resources: Focus On Treatment-Resistant Depression Paying Off
Atai Life Sciences: Long On Money; Short On Success